SEC Comment Letter for Greater Cannabis Company, Inc. (GCAN) (CIK 0001695473) (TRFA) — Jul 12, 2019
Greater Cannabis Company, Inc. (GCAN) (CIK 0001695473)
Date: July 12, 2019 · CIK: 0001695473 · Accession: 0000000000-19-011077
AI Filing Summary & Sentiment
File numbers found in text: 000-56027
Letter
July 12, 2019 Aitan Zacharin President and Acting Chief Financial Officer Greater Cannabis Company, Inc. 15 Walker Ave, Suite 101 Baltimore, MD 21208 Re:Greater Cannabis Company, Inc. Form 10-K for the fiscal year ended December 31, 2018 Filed April 15, 2019 File No. 000-56027 Dear Mr. Zacharin: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Form 10-K for the fiscal year ended December 31, 2018 Item 9A. Controls and Procedures, page 16 1.You are required to include a report of management's assessment regarding internal control over financial reporting in your Form 10-K due to to the passage of time since your initial registration statement and the number of Form 10-Ks filed since the initial registration statement. Please revise by amending your Form 10-K for the year ended December 31, 2018 to include this report as required by Item 308 of Regulation S-K. 2.You disclose that management concluded that your disclosure controls and procedures were not effective. Please add a separate risk factor that your disclosure controls and procedures were not effective as of December 31, 2018. Please explain why your disclosure controls and procedures were not effective. Describe any material weaknesses you have identified, your plans to remediate those weaknesses, and any associated material costs that you expect to incur.
FirstName LastNameAitan Zacharin Comapany NameGreater Cannabis Company, Inc. July 12, 2019 Page 2 FirstName LastName Aitan Zacharin Greater Cannabis Company, Inc. July 12, 2019 Page 2 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Vanessa Robertson at 202-551-3649 or Christine Torney at 202-551- 3652 if you have questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
July 12, 2019
Aitan Zacharin
President and Acting Chief Financial Officer
Greater Cannabis Company, Inc.
15 Walker Ave, Suite 101
Baltimore, MD 21208
Re:Greater Cannabis Company, Inc.
Form 10-K for the fiscal year ended December 31, 2018
Filed April 15, 2019
File No. 000-56027
Dear Mr. Zacharin:
We have reviewed your filing and have the following comments. In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional comments.
Form 10-K for the fiscal year ended December 31, 2018
Item 9A. Controls and Procedures, page 16
1.You are required to include a report of management's assessment regarding internal
control over financial reporting in your Form 10-K due to to the passage of time since
your initial registration statement and the number of Form 10-Ks filed since the initial
registration statement. Please revise by amending your Form 10-K for the year ended
December 31, 2018 to include this report as required by Item 308 of Regulation S-K.
2.You disclose that management concluded that your disclosure controls and procedures
were not effective. Please add a separate risk factor that your disclosure controls and
procedures were not effective as of December 31, 2018. Please explain why your
disclosure controls and procedures were not effective. Describe any material weaknesses
you have identified, your plans to remediate those weaknesses, and any associated
material costs that you expect to incur.
FirstName LastNameAitan Zacharin
Comapany NameGreater Cannabis Company, Inc.
July 12, 2019 Page 2
FirstName LastName
Aitan Zacharin
Greater Cannabis Company, Inc.
July 12, 2019
Page 2
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
You may contact Vanessa Robertson at 202-551-3649 or Christine Torney at 202-551-
3652 if you have questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance